Francine Carew-Jonesprofile image

Francine Carew-Jones


Current Appointments

Brain donor liaison officer
Senior Research Officer UNSW
email hidden; JavaScript is required

Francine has worked at NeuRA since March 2000, after completing her degree. Starting her career as a full-time research assistant working on Parkinson’s disease research with Dr Kay Double. After this time, she has worked with Professor Glenda Halliday and Dr Claire Shepherd focusing on dementia research.

She now works part-time as the Sydney Brain Bank Liaison Officer, managing relationships between the Sydney Brain Bank and the Brain Donor Programs. Francine also manages the NeuRA Volunteers brain donor program, recruiting healthy brain donors over the age of 60.

Francine is also involved with Dr Claire Shepherd’s research studies.


Publications

2020, 02 Jun

Alzheimer's amyloid-β and tau protein accumulation is associated with decreased expression of the LDL receptor-associated protein in human brain tissue.

View full journal-article on https://europepmc.org/articles/PMC7375106

2020, 01 Mar

CYLD is a causative gene for frontotemporal dementia - amyotrophic lateral sclerosis.

View full journal-article on https://europepmc.org/articles/PMC7089666

2019, 08 Nov

Intracellular and secreted forms of clusterin are elevated early in Alzheimer's disease and associate with both Aβ and tau pathology.

View full journal-article on https://doi.org/10.1016/j.neurobiolaging.2019.10.025

2019, 24 Apr

Coexisting Lewy body disease and clinical parkinsonism in frontotemporal lobar degeneration.

View full journal-article on https://doi.org/10.1212/WNL.0000000000007530

2014, 24 Jan

Increased Ndfip1 in the substantia nigra of Parkinsonian brains is associated with elevated iron levels.

View full journal-article on https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24475238/?tool=EBI

2010, 29 Jan

Substantia nigra echomorphology and motor cortex excitability.

View full journal-article on https://doi.org/10.1016/j.neuroimage.2010.01.088

2009, 13 Mar

Anti-melanin antibodies are increased in sera in Parkinson's disease.

View full journal-article on https://doi.org/10.1016/j.expneurol.2009.03.002

2007 Jan

Lipid content determines aggregation of neuromelanin granules in vitro.

View full journal-article on http://europepmc.org/abstract/med/17982875

2005, 31 Aug

Differential effects of human neuromelanin and synthetic dopamine melanin on neuronal and glial cells.

View full journal-article on https://doi.org/10.1111/j.1471-4159.2005.03404.x

2005 Jul

Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.

View full journal-article on http://europepmc.org/abstract/med/16000336